Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.


TSXV:MIR - Post by User

Bullboard Posts
User Avatar Image
(5)
•••
Post by AHybridofStreetandStocksmartson Dec 17, 2012 12:01am
244 Views
Post# 20738559

To buy another 100,000 MIR or not to buy...

To buy another 100,000 MIR or not to buy...

That is the question...four things that I can think of could happen in 2013:

1) We get the long awaited FDA approval  and the stock takes off to 0.50 cents or higher.

2) Private placement, further dilution, more delusional investors join the circus.

3) The Private placement (if any) does not go through, the stock gets delisted.

4) 2 or 3 with a happy ending.  Large pharmaceuticals company purchases Medmira with an offer that you cannot refuse...

Please vote as to which one is most likely.  Let's have some guesses/fun

Bullboard Posts